Dr. Ari Joseph Rosenberg, MD

Dr. Rosenberg practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Dr. Rosenberg's NPI, 1699017715, was assigned on March 27, 2013. Dr. Rosenberg holds Illinois license 036138973.

Dr. Rosenberg's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Rosenberg's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dr. Rosenberg is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Rosenberg to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenberg practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rosenberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rosenberg is licensed in Illinois.

CMS data shows 647 Medicare services from Dr. Rosenberg across 7 procedure codes in 2024, for 207 Medicare patients. Medicare paid $54,326 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 207 Medicare patients who saw Dr. Rosenberg in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosenberg's median patient age at 70, with 38% women.

In 2024, Dr. Rosenberg wrote 367 Medicare Part D claims for 90 patients. 64% of them were for generic drugs. CMS names the drug for 156 of them, across 6 drugs with 11 or more claims each, at $1,175,440 in total drug cost. In 2023, CMS named 153 claims across 7 drugs.

Dr. Rosenberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosenberg as offering telehealth.

Dmand AI links 71 papers to Dr. Rosenberg, published from 2013 to 2025. 2025 was the busiest year, with 13. The most frequent topics are Head and Neck Neoplasms, Photic Stimulation and Squamous Cell Carcinoma of Head and Neck. Dr. Rosenberg has published most often in Oral Oncol. Dr. Rosenberg's most frequent co-authors are Nishant Agrawal, Alexander T. Pearson and Aditya Juloori, MD.

Dmand AI links Dr. Rosenberg to 6 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Motion Sickness, Vertigo and Carcinoma, Merkel Cell. University of Wisconsin, Madison sponsors the most, 2.

CMS Open Payments shows 58 general payments to Dr. Rosenberg from 16 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 82% of the total. EMD Serono, Inc. paid the most, $16,211. It also lists 2 research payments totaling $1,262 in 2023.